[The importance and role of sclerotization in the therapy of esophageal varices in children].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Vavrecka.
Explore the source record for details and available documents.
Author describes own experience with endoscopic papilosphincterotomy which performed in 29 patients as the first in Czechoslovakia. He succeeded in 29 out of 33 patients, i.e. in 87.9% of cases. Endoscopic papilosphincterotomy was indicated in 24 patients (82.6%) with choledocholithiasis and in 5 patients with benign stenosis of papilla of Vater. In all patients with choledocholithiasis the removal of concretions from biliary passages was successful: in 8 cases (33.3%) they were spontaneously released, in remaining 16 cases (66.7%) they were extracted using the Dormia's basket. In the group of 29 patients, in 2 cases (7.8%) was observed cholangitis which was cured by combined treatment with antibiotics and antispasmodics. Urgent surgery was not necessary in any case.
The authors performed from 1983 86 gastrofiberoscopic diathermocoagulations and 132 colonoscopic polypectomies. The finding of the high number of adenomas in the stomach - 22.35%/63.15% in diameter to 10 mm/-is surprising. As to complications they recorded in one case mucosal bleeding after gastrofiberoptic polypectomy and in one case a covered perforation of the sigmoid at the site of colonoscopic polypectomy. The discussion is devoted to the present views of the importance of the endoscopic polypectomy in the diagnosis and treatment of polyps in the gastrointestinal tract with the accentuation of the problems of the endoscopic polypectomy from the proximal part of the digestive tube. The authors state the necessity to keep this method for removal of the gastric hyperplasiogenous polyps and the polyps to 10 mm in diameter. Finally, the advantages of the endoscopic polypectomy: unpretentiousness, no risk for patient, high diagnostic and therapeutic value and the economy, as compared with transabdominal surgical approach, are stressed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
BACKGROUND/AIMS: Between 1996 and 1998 we investigated the occurrence of lung disorders in 82 patients with inflammatory bowel disease (30 patients with ulcerative colitis and 52 patients with Crohn's disease) and a control group of 60 subjects. The aim of our study was to determine the occurrence of pulmonary complications in patients with inflammatory bowel disease, to investigate whether ulcerative colitis or Crohn's disease are connected with a typical lung function disorder, with the inflammatory activity of the disease or if they depend on the presence of other extraintestinal manifestations. METHODOLOGY: We investigated the occurrence of lung disorders in terms of the following parameters: clinical pulmonary symptoms, chest radiography and pulmonary function tests (body plethysmography, pneumotachography, lung transfer capacity for carbon monoxide, and blood gas analysis). RESULTS: Lung function abnormalities were significantly more frequent in patients with inflammatory bowel disease as compared to controls (p<0.001). There was no apparent correlation between these abnormalities and either bowel disease activity or drug administration (sulphasalazine, mesalazine). CONCLUSIONS: Despite the lack of radiological abnormalities, we identified a high incidence of pulmonary function abnormalities (suspicious of interstitial lung disorder) in patients with inflammatory bowel disease; 56.7% of patients with ulcerative colitis and 57.7% of patients with Crohn's disease had reduced lung transfer factor.